Skip to main content
Premium Trial:

Request an Annual Quote

BGI-Shenzhen Extends Complete Genomics Offer

NEW YORK (GenomeWeb News) – BGI-Shenzhen has extended its cash tender offer for Complete Genomics again, BGI announced late Friday.

The deal is now set to expire midnight EST, Feb. 1. It had been previously extended until midnight EST, Jan. 25.

The depositary for the offer has indicated that about 30,949,757 shares, or 87 percent, of Complete's common stock, have been validly tendered and not withdrawn. The $118 million deal has met various regulatory approvals, but a week ago BGI said that China's Ministry of Commerce and the State Administration of Foreign Exchange had not yet approved the acquisition. It did not update the status of those reviews on Friday.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.